Search

everythinglearnresearchcommunity

for

Search:↓

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Policosanol biorefining shows promise for heart health, needing better academic-industrial collaboration.

The niosomes effectively target hair follicles for acne treatment.

Combining lifestyle changes and medication is most effective for managing PCOS symptoms.

Advanced therapy medicinal products show promise for vitiligo treatment with fewer side effects, but affordability is a challenge.

Injectable biostimulators can improve skin by boosting collagen and fat cell activity, but more research is needed to confirm their safety and effectiveness.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Supplements improved calves' haircoat condition.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Some people have a genetic variation that makes them less effective at breaking down drugs.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Different lab conditions and light treatment methods change how human skin cells respond to light therapy.

Lifestyle changes are more effective than metformin in reducing type 2 diabetes risk in women with PCOS.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Biotin tablets and shampoo effectively stop hair loss and restore hair function in women.

BOOST is a promising, easy-to-use treatment for diabetic foot ulcers that improves healing by reducing inflammation and promoting blood vessel growth.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Rifampicin effectively treated tufted hair folliculitis with no relapse after one year.

Drug repurposing finds new uses for old drugs quickly and cheaply.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

Biotechnology could lead to new hair growth products.

Acinetobacter strain A1-4-2 can safely clean water pollutants.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.

More research is needed to confirm the potential of various treatments, including Helichrysum plicatum, vitamins, bromelain, personalized medications, hydrogels, and bacteriophage therapy.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.